Severity
Moderate
FDA Drug recall · Reported October 2, 2024
Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.
Guru Inc. recalled Infla-650 Herbal Dietary Supplement, 700mg, packaged in pouches containing 60 capsules, … - a moderate-severity action.
Infla-650 Herbal Dietary Supplement, 700mg, packaged in pouches containing 60 capsules, … was recalled by Guru Inc. in October 2, 2024. Reason: Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen…. Check the official notice for the remedy. Verify recall #D-0666-2024 with the FDA Drug before acting.
The recall
Guru Inc. issued this moderate-severity FDA Drug recall-Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen….
Sourced from official FDA Drug enforcement records. Verify recall #D-0666-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0666-2024) was formally reported on October 2, 2024, with the manufacturer initiating the action on June 26, 2024. It is classified under Moderate severity (Class II), with a current status of Ongoing. Guru Inc. is listed as the recalling firm, operating out of Lilburn, GA. The number of affected units is not disclosed in the agency filing, which is common for drug and food recalls where lot-level tracking supersedes unit counts.
The documented reason for this recall is: Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone. Distribution data in the federal record shows the product reached: Retail: South Carolina, North Carolina, Ohio; Consumer level: Nationwide within USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
Unknown
Related Recalls
6
5 from same agency
Infla-650 Herbal Dietary Supplement, 700mg, packaged in pouches containing 60 capsules, Distributed by: Guru Inc., 4370 Lawrenceville Hwy NW, P.O. Box 2204, Lilburn, GA 30047-1100, USA. Ph.: 872 216 1566, http://www.dalayurevda.com, Made in India, UPC: 042535355019
Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0666-2024 |
| Date reported | October 2, 2024 |
| Date initiated | June 26, 2024 |
| Recalling firm | Guru Inc. |
| Firm location | Lilburn, GA |
| Affected scope | Not disclosed |
| Distribution | Retail: South Carolina, North Carolina, Ohio; Consumer level: Nationwide within USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 2, 2024. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.